PharmaShots Weekly Snapshots (Feb 08 - 12, 2021)
Visby's POC COVID-19 Test Receives the US FDA's EUA for Use in CLIA Waived Settings
Published: Feb 12, 2020 | Tags: Visby, POC, COVID-19, Test, Receives, US, FDA, EUA, Use, CLIA, Waived, Settings
Takeda Collaborates with Ensoma to Accelerate Next-Generation In Vivo Gene Therapies
Published: Feb 12, 2020 | Tags: Takeda, Collaborates, Ensoma, Accelerate, Next-Generation, Vivo Gene Therapies
Published: Feb 12, 2020 | Tags: Roche, Reports, Results, Faricimab, Four, P-III, Studies, Diabetic, Macular Edema, Age-Related Macular Degeneration
Published: Feb 12, 2020 | Tags: Regeneron, Evkeeza (evinacumab-dgnb), Receives, US, FDA, Approval, Patients, Homozygous Familial Hypercholesterolemia
Novartis to Acquire GSK's Cephalosporin Antibiotics Business
Published: Feb 12, 2020 | Tags: Novartis, Acquire, GSK, Cephalosporin, Antibiotics, Business
BMS Collaborates with Molecular Templates to Develop Engineered Toxin Body Therapies for Cancer
Published: Feb 12, 2020 | Tags: BMS, Collaborates, Molecular Templates, Develop, Engineered, Toxin, Body, Therapies, Cancer
Evotec Collaborates with Related Sciences for Drug Discovery and Development
Published: Feb 11, 2020 | Tags: Evotec, Collaborates, Related Sciences, Drug Discovery, Development
Published: Feb 11, 2020 | Tags: AstraZeneca, Signs, Letter, Intent, IDT Biologika, Boost, COVID-19 Vaccine, Manufacturing, Capability, EU
Sanofi Collaborates with i2O Therapeutics to Evaluate Oral i2O Therapeutics
Published: Feb 11, 2020 | Tags: Sanofi, Collaborates, i2O Therapeutics, Evaluate, Oral, i2O Therapeutics
AbbVie Signs a License Agreement with Caribou Biosciences for CAR-T Cell Therapies
Published: Feb 11, 2020 | Tags: AbbVie, Signs, License Agreement, Caribou Biosciences, CAR-T Cell Therapies
Published: Feb 11, 2020 | Tags: Galapagos, Gilead, Discontinue, P-III, Trials, Ziritaxestat (GLPG1690), Idiopathic Pulmonary Fibrosis
Kaia Health Offers a Complete Musculoskeletal Care Solution with Kaia Gateway and Premium Partners
Published: Feb 11, 2020 | Tags: Kaia Health, Offers, Complete, Musculoskeletal Care Solution, Kaia Gateway, Premium Partners
Lonza to Divest Specialty Ingredients Business to Bain Capital and Cinven for $4.7B
Published: Feb 10, 2020 | Tags: Lonza, Divest, Specialty, Ingredients, Business, Bain Capital, Cinven ,$4.7B
Vico's VO659 Receives EC's Orphan Drug Designation for Spinocerebellar Ataxia
Published: Feb 10, 2020 | Tags: Vico, VO659, Receives, EC, Orphan Drug Designation, Spinocerebellar Ataxia
Lannett Expand its Partnership with HEC to Include Biosimilar Fast-Acting Insulin
Published: Feb 10, 2020 | Tags: Lannett, Expand, Partnership, HEC, Include, Biosimilar, Fast-Acting, Insulin
Published: Feb 10, 2020 | Tags: Eli Lilly, AbCellera, Bamlanivimab (LY-CoV555), Etesevimab (LY-CoV016), Receive, US, FDA, EUA, COVID-19
Published: Feb 10, 2020 | Tags: Regeneron, Sanofi, Libtayo (cemiplimab-rwlc), Receives, US, FDA, Approval, Patients, Advanced Basal Cell Carcinoma
Published: Feb 10, 2020 | Tags: Lee's Pharma, Socazolimab, Receives, NMPA, Breakthrough Therapy Designation, Treatment, Recurrent, Metastatic, Cervical Cancer
BMS Report Results of Opdivo (nivolumab) + Cabometyx (cabozantinib) in P-III CheckMate -9ER Trial for 1L Treatment of Advanced Renal Cell Carcinoma
Published: Feb 9, 2020 | Tags: BMS, Report, Results, Opdivo (nivolumab), Cabometyx (cabozantinib), P-III, CheckMate -9ER Trial, 1L, Treatment, Advanced Renal Cell Carcinoma
Medidata Launches Sensor Cloud to Connect Device and Wearables in Clinical Trials
Published: Feb 9, 2020 | Tags: Medidata, Launches, Sensor Cloud, Connect, Device, Wearables, Clinical Trials
Published: Feb 9, 2020 | Tags: BMS, Inrebic (fedratinib), Receives, EC, Approval, Patients, Newly Diagnosed, Previously, Treated, Myelofibrosis
Published: Feb 9, 2020 | Tags: Signifie, eXciteOSA, Receives, US, FDA, Approval, Treatment, Mild Obstructive, Sleep Apnea, Snoring
Hologic Collaborate with Google Cloud to Advance Screening in Cervical Cancer
Published: Feb 9, 2020 | Tags: Hologic, Collaborate, Google Cloud, Advance, Screening, Cervical Cancer
Published: Feb 9, 2020 | Tags: ViiV Healthcare, Rukobia (fostemsavir), Receives, Marketing Authorization, Treatment, Adults, Multidrug-Resistant HIV
Published: Feb 8, 2020 | Tags: Celltrion, Regdanvimab (CT-P59), Receives, Korean, MFDS, Conditional Marketing Authorization, COVID-19
AstraZeneca's Imfinzi Fails to Meet its Primary Endpoints in P-III KESTREL Study
Published: Feb 8, 2020 | Tags: AstraZeneca, Imfinzi, Fails, Meet, Primary Endpoints, P-III, KESTREL ,Study
CureVac Collaborate with UK Government to Develop Vaccines Against SARS-CoV-2 variants
Published: Feb 8, 2020 | Tags: CureVac, Collaborate, UK, Government, Develop, Vaccines, Against, SARS-CoV-2 variants
Published: Feb 8, 2020 | Tags: Roche, Elecsys, GDF-15, Assay, Receives, US, FDA, Breakthrough Device Designation, CDX, Cancer, Treatment
Daiichi Sankyo Signs an Outsourcing Agreement with AstraZeneca for COVID-19 Vaccine in Japan
Published: Feb 8, 2020 | Tags: Daiichi Sankyo, Signs, Outsourcing Agreement, AstraZeneca, COVID-19, Vaccine, Japan
Published: Feb 8, 2020 | Tags: BMS, Breyanzi (lisocabtagene maraleucel), Receives, US, FDA, Approval, Adults, R/R Large-B-Cell Lymphoma
Related post: PharmaShots Weekly Snapshot (Feb 01-05, 2021)
Tags
This content piece was prepared by our former Senior Editor. She had expertise in life science research and was an avid reader. For any query reach out to us at connect@pharmashots.com